title: Reply: Bioresorbable Scaffold Thrombosis: Why BRS Size Matters.
authors.forename: Serban
authors.initials: S
authors.lastname: Puricel
authors.forename: Florim
authors.initials: F
authors.lastname: Cucul
authors.forename: Melissa
authors.initials: M
authors.lastname: Weissner
authors.forename: Axel
authors.initials: A
authors.lastname: Schmermund
authors.forename: Peiman
authors.initials: P
authors.lastname: Jamshidi
authors.forename: Tobias
authors.initials: T
authors.lastname: Nyffenegger
authors.forename: Harald
authors.initials: H
authors.lastname: Binder
authors.forename: Holger
authors.initials: H
authors.lastname: Eggebrecht
authors.forename: Thomas
authors.initials: T
authors.lastname: Münzel
authors.forename: Stephane
authors.initials: S
authors.lastname: Cook
authors.forename: Tommaso
authors.initials: T
authors.lastname: Gori
mesh_terms: D020341:Absorbable Implants; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention; D011474:Prosthesis Design; D013927:Thrombosis; D054457:Tissue Scaffolds